X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse SHASUN PHARMA with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SHASUN PHARMA   MYLAN
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
MYLAN
Dec-14
SHASUN PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs944,042-   
Low Rs462,848-   
Sales per share (Unadj.) Rs214.21,383.8-  
Earnings per share (Unadj.) Rs5.3166.7-  
Cash flow per share (Unadj.) Rs15.8268.3-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %1.40-  
Book value per share (Unadj.) Rs53.3687.9-  
Shares outstanding (eoy) m56.62378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x0.32.5 13.1%   
Avg P/E ratio x13.120.7 63.4%  
P/CF ratio (eoy) x4.412.8 34.4%  
Price / Book Value ratio x1.35.0 26.2%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m3,9581,303,581 0.3%   
No. of employees `000NA25.0 0.0%   
Total wages/salary Rs m2,1640-   
Avg. sales/employee Rs ThNM20,942.8-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,522.9-  
INCOME DATA
Net Sales Rs m12,127523,570 2.3%  
Other income Rs m229-3,052 -7.5%   
Total revenues Rs m12,356520,519 2.4%   
Gross profit Rs m1,009130,214 0.8%  
Depreciation Rs m59438,454 1.5%   
Interest Rs m41522,584 1.8%   
Profit before tax Rs m23066,125 0.3%   
Minority Interest Rs m0-271 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-732,781 -2.6%   
Profit after tax Rs m30263,073 0.5%  
Gross profit margin %8.324.9 33.5%  
Effective tax rate %-31.74.2 -752.9%   
Net profit margin %2.512.0 20.7%  
BALANCE SHEET DATA
Current assets Rs m6,884460,288 1.5%   
Current liabilities Rs m8,456359,853 2.3%   
Net working cap to sales %-13.019.2 -67.6%  
Current ratio x0.81.3 63.6%  
Inventory Days Days6278 78.9%  
Debtors Days Days108107 100.3%  
Net fixed assets Rs m4,970121,127 4.1%   
Share capital Rs m11318,515 0.6%   
"Free" reserves Rs m2,8750-   
Net worth Rs m3,020260,266 1.2%   
Long term debt Rs m1,817388,812 0.5%   
Total assets Rs m13,3471,048,328 1.3%  
Interest coverage x1.63.9 39.5%   
Debt to equity ratio x0.61.5 40.3%  
Sales to assets ratio x0.90.5 181.9%   
Return on assets %5.48.2 65.8%  
Return on equity %10.024.2 41.3%  
Return on capital %13.313.6 97.8%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Net fx Rs m3,6690-   
CASH FLOW
From Operations Rs m39868,824 0.6%  
From Investments Rs m-1,635-54,276 3.0%  
From Financial Activity Rs m1,309-18,135 -7.2%  
Net Cashflow Rs m71-3,588 -2.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 67.82 Rs / USD

Compare SHASUN PHARMA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SHASUN PHARMA With: J.B.CHEMICALS  ELDER PHARMA  ALEMBIC PHARMA  GSK PHARMA  NOVARTIS  



Today's Market

Sensex Trades on a Volatile Note; Idea Cellular Plunges 6%(12:30 pm)

After opening the day flat share markets in India are trading on a dull note and are presently trading marginally below the dotted line.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 8-QTR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS